Your search returned 3 results.

Results
	1.	Cost-effectiveness of adding bevacizumab to first line therapy for patients with advanced ovarian cancer. [electronic resource] by Mehta, Darshan A Hay, Joel W Producer: 20140428 In: Gynecologic oncology vol. 132 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A Budget Impact Model of Hemophilia Bypassing Agent Prophylaxis Relative to Recombinant Factor VIIa On-Demand. [electronic resource] by Mehta, Darshan A Oladapo, Abiola O Epstein, Joshua D Novack, Aaron R Neufeld, Ellis J Hay, Joel W Producer: 20161216 In: Journal of managed care & specialty pharmacy vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Effect of Hepatitis C Treatment with Ombitasvir/Paritaprevir/R + Dasabuvir on Renal, Cardiovascular and Metabolic Extrahepatic Manifestations: A Post-Hoc Analysis of Phase 3 Clinical Trials. [electronic resource] by Mehta, Darshan A Cohen, Eric Charafeddine, Mariem Cohen, Daniel E Bao, Yanjun Sanchez Gonzalez, Yuri Tran, Tram T Publication details: Infectious diseases and therapy Dec 2017 In: Infectious diseases and therapy vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search